| 1. |
The Scottish Medicines Consortium (SMC) has issued guidance to the Scottish NHS regarding adefovir dipivoxil and aripiprazole. |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Migraine costs sizeable, with or without comorbidity |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Epilepsy accounts for increased costs in Burundi |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Basiliximab good value for money in renal transplantation |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Hexavalent group A streptococcal vaccine induces immune responses |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
LAF 237: improved glycaemic control in type 2 diabetes mellitus |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 7-8
C Innes,
Preview
|
|
摘要:
LAF 237 [NVP LAF 237], the first in a new class of drugs called dipeptidyl peptidase (DPP)-4 inhibitors, is effective in patients with type 2 diabetes mellitus who had not achieved adequate glycaemic control with metformin, according to a study presented at the 64th Scientific Sessions of the American Diabetes Association [Orlando, Florida, USA; June, 2004]. During the year-long study, patients treated with oral LAF 237 plus metformin sustained an HbA1clevel that was on average 1.1% lower than that observed in patients treated with placebo plus metformin. A second study presented at the meeting indicated that LAF 237 is also effective in the treatment of type 2 diabetes when given as monotherapy.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Dalbavancin equivalent to linezolid, cefazolin, vancomycin for SSTI |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Vaccinated patients with chickenpox are less contagious |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
PEG IFN-α-2b + ribavirin: 24 weeks sufficient for HCV-2 and HCV-3? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
EGFR mutations underlie the responsiveness of NSCLC to gefitinib |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1451,
2004,
Page 11-11
MI Wilde,
Preview
|
|
摘要:
Mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase domain determine the response to gefitinib [ZD1839, Iressa] in the majority of patients with advanced non-small-cell lung cancer (NSCLC), according to two studies presented at the 40th Annual Meeting of the American Society for Clinical Oncology [New Orleans, US; June 2004]. The topic was also discussed during a symposium entitled 'Epidermal Growth Factor Receptor Inhibition: Unanswered Questions and Strategies for Patient Care.'
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
